Abstract

PurposeCandidemia is an alarming problem in critically ill patients including those admitted in intensive care units (ICUs). We aimed to describe the clinical and microbiological characteristics of bloodstream infections (BSIs) due to Candida spp. in patients admitted to ICUs of an italian tertiary referral university hospital over nine years.MethodsA retrospective observational study of all cases of candidemia in adult patients was carried out from January 1, 2010 to December 31, 2018 at a 980-bedded University Hospital in Ancona, Italy, counting five ICUs. The incidence, demographics, clinical and microbiologic characteristics, therapeutic approaches and outcomes of ICU-patients with candidemia were collected. Non-ICU patients with candidemia hospitalized during the same time period were considered for comparison purposes. Early (7 days from the occurrence of the episode of Candida BSI) and late (30 days) mortality rates were calculated.ResultsDuring the study period, 188/505 (36%) episodes of candidemia occurred in ICU patients. Cumulative incidence was 9.9/1000 ICU admission and it showed to be stable over time. Candida albicans accounted for 52% of the cases, followed by C. parapsilosis (24%), and C. glabrata (14%). There was not a significant difference in species distribution between ICU and non-ICU patients. With the exception of isolates of C. tropicalis which showed to be fluconazole resistant in 25% of the cases, resistance to antifungals was not of concern in our patients. Early and late mortality rates, were 19% and 41% respectively, the latter being significantly higher than that observed in non-ICU patients. At multivariate analysis, factors associated with increased risk of death were septic shock, acute kidney failure, pulmonary embolism and lack of antifungal therapy. The type of antifungal therapy did not influence the outcome. Mortality did not increased significantly over time.ConclusionNeither cumulative incidence nor crude mortality of candidemia in ICU patients increased over time at our institution. However, mortality rate remained high and significantly associated with specific host-related factors in the majority of cases.

Highlights

  • Invasive fungal diseases and in particular candidemia, are an alarming problem in critically ill patients including those admitted in intensive care units (ICUs)

  • Candida albicans accounted for 52% of the cases, followed by C. parapsilosis (24%), and C. glabrata (14%)

  • Neither cumulative incidence nor crude mortality of candidemia in ICU patients increased over time at our institution

Read more

Summary

Introduction

Invasive fungal diseases and in particular candidemia, are an alarming problem in critically ill patients including those admitted in intensive care units (ICUs). The implementation of antifungals for empiric or preemptive strategies in critically ill patients, has led to the emergence of Candida spp. that are resistant to azoles and/or echinocandins [10,11,12,13]. Most of these studies focused on specific populations or they were conducted for a limited period of time [14, 15]. The primary objective of the present study was to estimate the cumulative incidence of bloodstream infections (BSIs) due to Candida spp. in patients admitted to ICUs of an italian tertiary referral university hospital over nine years. Non-ICU patients with candidemia hospitalized during the same time period were considered for comparison purposes

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call